
Radio and PodcastLive Radio & Podcasts
151 - PU-H71 for myelofibrosis; RGX-111 for Mucopolysaccharidosis; Moxidectin For The Treatment Of River Blindness; Wearable Device to Treat Opioid Addiction; FDA Clearance For Thrombectomy Device
151 - PU-H71 for myelofibrosis; RGX-111 for Mucopolysaccharidosis; Moxidectin For The Treatment Of River Blindness; Wearable Device to Treat Opioid Addiction; FDA Clearance For Thrombectomy Device is an episode from New...
About This Episode
151 - PU-H71 for myelofibrosis; RGX-111 for Mucopolysaccharidosis; Moxidectin For The Treatment Of River Blindness; Wearable Device to Treat Opioid Addiction; FDA Clearance For Thrombectomy Device is an episode from New FDA Approvals. This...
This episode belongs to New FDA Approvals.
Use the player on this page to stream the episode online.
Published Jun 14, 2018, 15:58 long, audio available.
Questions About This Episode
What is 151 - PU-H71 for myelofibrosis; RGX-111 for Mucopolysaccharidosis; Moxidectin For The Treatment Of River Blindness; Wearable Device to Treat Opioid Addiction; FDA Clearance For Thrombectomy Device about?
151 - PU-H71 for myelofibrosis; RGX-111 for Mucopolysaccharidosis; Moxidectin For The Treatment Of River Blindness; Wearable Device to Treat Opioid Addiction; FDA Clearance For Thrombectomy Device is a podcast episode from New FDA Approvals. You can listen online and use the related episode section to continue with more content from the same show.
Where can I listen to 151 - PU-H71 for myelofibrosis; RGX-111 for Mucopolysaccharidosis; Moxidectin For The Treatment Of River Blindness; Wearable Device to Treat Opioid Addiction; FDA Clearance For Thrombectomy Device?
You can listen to 151 - PU-H71 for myelofibrosis; RGX-111 for Mucopolysaccharidosis; Moxidectin For The Treatment Of River Blindness; Wearable Device to Treat Opioid Addiction; FDA Clearance For Thrombectomy Device online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is 151 - PU-H71 for myelofibrosis; RGX-111 for Mucopolysaccharidosis; Moxidectin For The Treatment Of River Blindness; Wearable Device to Treat Opioid Addiction; FDA Clearance For Thrombectomy Device from?
151 - PU-H71 for myelofibrosis; RGX-111 for Mucopolysaccharidosis; Moxidectin For The Treatment Of River Blindness; Wearable Device to Treat Opioid Addiction; FDA Clearance For Thrombectomy Device is an episode from New FDA Approvals.
How long is this episode?
This episode is 15:58 long.
When was this episode published?
This episode was published on Jun 14, 2018.
Can I save 151 - PU-H71 for myelofibrosis; RGX-111 for Mucopolysaccharidosis; Moxidectin For The Treatment Of River Blindness; Wearable Device to Treat Opioid Addiction; FDA Clearance For Thrombectomy Device for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from New FDA Approvals?
Yes. This page shows related episodes from New FDA Approvals when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to 151 - PU-H71 for myelofibrosis; RGX-111 for Mucopolysaccharidosis; Moxidectin For The Treatment Of River Blindness; Wearable Device to Treat Opioid Addiction; FDA Clearance For Thrombectomy Device?
You can listen to 151 - PU-H71 for myelofibrosis; RGX-111 for Mucopolysaccharidosis; Moxidectin For The Treatment Of River Blindness; Wearable Device to Treat Opioid Addiction; FDA Clearance For Thrombectomy Device on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
151 - PU-H71 for myelofibrosis; RGX-111 for Mucopolysaccharidosis; Moxidectin For The Treatment Of River Blindness; Wearable Device to Treat Opioid Addiction; FDA Clearance For Thrombectomy Device is from New FDA Approvals.
What are the episode details?
Published Jun 14, 2018 and 15:58 long